| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypertension | D006973 | 115 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wang ST et al. | Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. | 2013 | Clin. Nephrol. | pmid:23073066 |
| Honma M et al. | RANKL subcellular trafficking and regulatory mechanisms in osteocytes. | 2013 | J. Bone Miner. Res. | pmid:23529793 |
| Vinholt PJ et al. | An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. | 2013 | Thromb. Res. | pmid:23531238 |
| Shang M et al. | Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. | 2013 | Clin. Biochem. | pmid:23531404 |
| Jin J et al. | Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. | 2013 | J. Surg. Res. | pmid:22487394 |
| Janda K et al. | Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. | 2013 | Pol. Arch. Med. Wewn. | pmid:23535831 |
| Zhan X et al. | Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. | 2013 | Dent Traumatol | pmid:22487464 |
| Tripuwabhrut P et al. | Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. | 2013 | Arch. Oral Biol. | pmid:23583016 |
| Brzóska MM and Rogalska J | Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. | 2013 | Toxicol. Appl. Pharmacol. | pmid:23726800 |
| Kim J et al. | Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. | 2013 | Clin. Biochem. | pmid:23726804 |
| Saini V et al. | Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. | 2013 | J. Biol. Chem. | pmid:23729679 |
| Wan S | Editorial comment: The end of all our exploring ... | 2013 | Eur J Cardiothorac Surg | pmid:23729753 |
| Recht M et al. | The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. | 2013 | Haemophilia | pmid:23731369 |
| Wu X et al. | Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. | 2013 | Eur. J. Med. Res. | pmid:23731710 |
| Araújo AA et al. | Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. | 2013 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:23775504 |
| Rozas Moreno P et al. | Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males? | 2013 | J. Endocrinol. Invest. | pmid:22391059 |
| Ma XN et al. | [Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts]. | 2013 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:23987492 |
| Naumnik B et al. | Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. | 2013 | Adv Med Sci | pmid:23959668 |
| Belibasakis GN et al. | The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease. | 2013 | Int Endod J | pmid:22900632 |
| Kim SD et al. | Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. | 2013 | Biochem. Pharmacol. | pmid:23928189 |
| Crosley LK et al. | The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. | 2013 | Mol Nutr Food Res | pmid:23934705 |
| Zhang J et al. | Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. | 2013 | PLoS ONE | pmid:23936431 |
| Bezerra JP et al. | Effects of estrogen deficiency and/or caffeine intake on alveolar bone loss, density, and healing: a study in rats. | 2013 | J. Periodontol. | pmid:22873654 |
| Lekesiz K et al. | Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. | 2013 | Folia Histochem. Cytobiol. | pmid:23907946 |
| Enhos S et al. | OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23910201 |
| Callegari A et al. | Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. | 2013 | Arterioscler. Thromb. Vasc. Biol. | pmid:23990207 |
| Oshita K et al. | [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. | 2013 | J. UOEH | pmid:23475022 |
| Kress DC | Invited commentary. | 2013 | Ann. Thorac. Surg. | pmid:23992687 |
| Mozzanega B et al. | Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. | 2013 | J. Bone Miner. Metab. | pmid:23479185 |
| de Matos FR et al. | Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors. | 2013 | J. Oral Maxillofac. Surg. | pmid:23992784 |
| Yano S et al. | Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. | 2013 | Zool. Sci. | pmid:23480382 |
| Yabumoto T et al. | Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23992809 |
| Ghaffari S et al. | The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. | 2013 | Cardiol J | pmid:23788300 |
| Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
| Anastasilakis AD et al. | Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. | 2013 | J. Clin. Endocrinol. Metab. | pmid:23788684 |
| Welldon KJ et al. | Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. | 2013 | Mol. Cell. Endocrinol. | pmid:23791847 |
| Aranha AM et al. | Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. | 2013 | J Endod | pmid:23228262 |
| Wang XF et al. | The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. | 2013 | Mol Med Rep | pmid:23440406 |
| Jiang S et al. | Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. | 2013 | Poult. Sci. | pmid:23687138 |
| Srivastava S et al. | Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. | 2013 | Phytomedicine | pmid:23570998 |
| Fu YX et al. | Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. | 2013 | Poult. Sci. | pmid:23687158 |
| Lou Z et al. | Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. | 2013 | Med. Oncol. | pmid:23690270 |
| Suliburska J et al. | The association of insulin resistance with serum osteoprotegerin in obese adolescents. | 2013 | J. Physiol. Biochem. | pmid:23695991 |
| Kato R et al. | Gap-junction-mediated communication in human periodontal ligament cells. | 2013 | J. Dent. Res. | pmid:23677649 |
| Weng CH et al. | [Effects of shangke jiegu tablet on the gene expressions of osteoprotegerin and osteoprotegerin ligand in the repairing process of mandibular defect rabbits]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:23596799 |
| Palumbo S and Li WJ | Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. | 2013 | Tissue Eng Part A | pmid:23597005 |
| Brown TT et al. | Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. | 2013 | J. Acquir. Immune Defic. Syndr. | pmid:23591634 |
| Feng X et al. | Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. | 2013 | Clin. Dev. Immunol. | pmid:24348674 |
| Levidou G et al. | TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. | 2013 | Pathology | pmid:23277172 |
| de Moraes M et al. | Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. | 2013 | J. Oral Pathol. Med. | pmid:23278112 |
| Peris P et al. | Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. | 2013 | Mayo Clin. Proc. | pmid:23228561 |
| Liu CG et al. | [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:24517065 |
| Zhang W et al. | IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. | 2013 | Inflammation | pmid:22945280 |
| Dieckmann M et al. | Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. | 2013 | J. Bone Miner. Res. | pmid:22991192 |
| Owen S et al. | Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. | 2013 | Anticancer Res. | pmid:23267146 |
| Lazzerini PE et al. | Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. | 2013 | Joint Bone Spine | pmid:22999910 |
| Shao B et al. | [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. | 2013 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:24321069 |
| Jiang H et al. | A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. | 2013 | BMC Pregnancy Childbirth | pmid:24321402 |
| Naranjo-Suarez S et al. | Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. | 2013 | Mol. Cells | pmid:23912593 |
| Dorotheou D et al. | Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. | 2013 | Orthod Craniofac Res | pmid:23311656 |
| Zhang J et al. | Occlusal effects on longitudinal bone alterations of the temporomandibular joint. | 2013 | J. Dent. Res. | pmid:23340211 |
| Feng ZY et al. | Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. | 2013 | Mol Med Rep | pmid:24126801 |
| Yang B et al. | Effect of radiation on the Notch signaling pathway in osteoblasts. | 2013 | Int. J. Mol. Med. | pmid:23340672 |
| Wang X et al. | Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. | 2013 | Chin. J. Traumatol. | pmid:24103822 |
| Lotinun S et al. | Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. | 2013 | J. Clin. Invest. | pmid:23321671 |
| Saki F et al. | Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. | 2013 | J. Bone Miner. Res. | pmid:23322328 |
| Srivastava S et al. | Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. | 2013 | Biol Trace Elem Res | pmid:23325289 |
| Osorio A et al. | Biochemical markers of vascular calcification in elderly hemodialysis patients. | 2013 | Mol. Cell. Biochem. | pmid:23124853 |
| Kim HS et al. | The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells. | 2013 | Int. J. Mol. Med. | pmid:23128413 |
| Mogelvang R et al. | Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. | 2013 | Heart | pmid:23135978 |
| Ciccone MM et al. | Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases. | 2013 | J Cardiovasc Med (Hagerstown) | pmid:22772598 |
| Wolf M et al. | Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. | 2013 | Clin Oral Investig | pmid:22777389 |
| Deng YH et al. | The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. | 2013 | Endocrine | pmid:22798246 |
| Pereira AC et al. | Histomorphometrical and molecular evaluation of endosseous dental implants sites in humans: correlation with clinical and radiographic aspects. | 2013 | Clin Oral Implants Res | pmid:22092653 |
| Nanjundaiah SM et al. | Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. | 2013 Jan-Mar | Int J Immunopathol Pharmacol | pmid:23527707 |
| Esteghamati A et al. | Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23877020 |
| Glintborg D et al. | Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23211475 |
| Zamora PO et al. | Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. | 2013 Mar-Apr | Int. J. Toxicol. | pmid:23422080 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Canto-Cetina T et al. | Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. | 2013 Nov-Dec | Am. J. Hum. Biol. | pmid:24130145 |
| Liu S et al. | Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. | 2013 Oct-Dec | Hormones (Athens) | pmid:24457406 |
| Chiang PH et al. | Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. | 2013 Oct-Dec | J Cancer Res Ther | pmid:24518712 |
| Marques EA et al. | Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. | 2013 Sep-Oct | Arch Gerontol Geriatr | pmid:23623588 |
| Guo L et al. | Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. | 2014 | DNA Cell Biol. | pmid:24283361 |
| Samara S et al. | Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. | 2014 | Exp. Mol. Pathol. | pmid:24200492 |
| Casarin RC et al. | Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. | 2014 | Int J Oral Maxillofac Surg | pmid:24530035 |
| D'Abramo A et al. | Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. | 2014 | Mediators Inflamm. | pmid:25374442 |
| Samir SM and Malek HA | Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. | 2014 | J. Physiol. Pharmacol. | pmid:25371528 |
| Arrigoni C et al. | Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. | 2014 | Mol. Cancer | pmid:25335447 |
| Hayashida C et al. | Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. | 2014 | J. Biol. Chem. | pmid:24610813 |
| Callegari A et al. | Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. | 2014 | J. Vasc. Res. | pmid:24642764 |
| Yan D et al. | Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. | 2014 | J Orthop Surg Res | pmid:25138985 |
| Schieferdecker A et al. | Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. | 2014 | Oncotarget | pmid:25138051 |
| Chung SL et al. | Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. | 2014 | J. Orthop. Res. | pmid:25131218 |
| Yoshida S et al. | An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. | 2014 | PLoS ONE | pmid:25105978 |
| Ohlsson C et al. | Probiotics protect mice from ovariectomy-induced cortical bone loss. | 2014 | PLoS ONE | pmid:24637895 |
| Loureiro MB et al. | Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. | 2014 | Diabetes Res. Clin. Pract. | pmid:24529565 |
| Sirjani M et al. | The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. | 2014 | Iran J Allergy Asthma Immunol | pmid:24659160 |
| Wang JH et al. | Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. | 2014 | J Clin Hypertens (Greenwich) | pmid:24640954 |
| Liu YP et al. | Association of the g.27563G>A osteoprotegerin genetic polymorphism with bone mineral density in Chinese women. | 2014 | Genet. Mol. Res. | pmid:24615112 |